United Therapeutics Corporation UTHR
Revenue Intelligence Report • 69 quarters of SEC filing data • Updated 2026-10-14 • Data through 2026-06-30
United Therapeutics Corporation has SEC quarterly revenue data through 2026-06-30. The updated spending model did not pass estimation or forecast-quality checks. Current reported revenue is shown while the forecast is withheld.
Trailing 4 Quarters
$3.15B
+2.5% YoY
SEC Filings
69 quarters
Profile-only page: The updated spending model did not pass estimation or forecast-quality checks. Current reported revenue is shown while the forecast is withheld.
Quarterly Revenue History
| Quarter Ending | Revenue |
|---|---|
| 2009-06-30 | $0.1B |
| 2009-09-30 | $0.1B |
| 2009-12-31 | $0.1B |
| 2010-03-31 | $0.1B |
| 2010-06-30 | $0.1B |
| 2010-09-30 | $0.2B |
| 2010-12-31 | $0.2B |
| 2011-03-31 | $0.2B |
| 2011-06-30 | $0.2B |
| 2011-09-30 | $0.2B |
| 2011-12-31 | $0.2B |
| 2012-03-31 | $0.2B |
| 2012-06-30 | $0.2B |
| 2012-09-30 | $0.2B |
| 2012-12-31 | $0.2B |
| 2013-03-31 | $0.2B |
| 2013-06-30 | $0.3B |
| 2013-09-30 | $0.3B |
| 2013-12-31 | $0.3B |
| 2014-03-31 | $0.3B |
| 2014-06-30 | $0.3B |
| 2014-09-30 | $0.3B |
| 2014-12-31 | $0.3B |
| 2015-03-31 | $0.3B |
| 2015-06-30 | $0.3B |
| 2015-09-30 | $0.4B |
| 2015-12-31 | $0.4B |
| 2016-03-31 | $0.4B |
| 2016-06-30 | $0.4B |
| 2016-09-30 | $0.4B |
| 2016-12-31 | $0.4B |
| 2017-03-31 | $0.4B |
| 2017-06-30 | $0.4B |
| 2017-09-30 | $0.4B |
| 2017-12-31 | $0.5B |
| 2018-03-31 | $0.4B |
| 2018-06-30 | $0.4B |
| 2018-09-30 | $0.4B |
| 2018-12-31 | $0.4B |
| 2019-03-31 | $0.4B |
| 2019-06-30 | $0.4B |
| 2019-09-30 | $0.4B |
| 2019-12-31 | $0.3B |
| 2020-03-31 | $0.4B |
| 2020-06-30 | $0.4B |
| 2020-09-30 | $0.4B |
| 2020-12-31 | $0.4B |
| 2021-03-31 | $0.4B |
| 2021-06-30 | $0.4B |
| 2021-09-30 | $0.4B |
| 2021-12-31 | $0.4B |
| 2022-03-31 | $0.5B |
| 2022-06-30 | $0.5B |
| 2022-09-30 | $0.5B |
| 2022-12-31 | $0.5B |
| 2023-03-31 | $0.5B |
| 2023-06-30 | $0.6B |
| 2023-09-30 | $0.6B |
| 2023-12-31 | $0.6B |
| 2024-03-31 | $0.7B |
| 2024-06-30 | $0.7B |
| 2024-09-30 | $0.7B |
| 2024-12-31 | $0.7B |
| 2025-03-31 | $0.8B |
| 2025-06-30 | $0.8B |
| 2025-09-30 | $0.8B |
| 2025-12-31 | $0.8B |
| 2026-03-31 | $0.8B |
| 2026-06-30 | $0.8B |
Want this analysis for your portfolio?
I build custom revenue intelligence reports for investors and companies using SEC filing data, econometric modeling, and AI-powered insights.
Get in Touch